
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Exosome
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Preclinical
Sponsor : NurExone Biologic
Deal Size : Undisclosed
Deal Type : Agreement
NurExone Signs Preclinical Testing Agreement for ExoPTEN Therapy
Details : Vivox will provide CRO services to NurExone to commence human trials, moving towards IND filing in the U.S. for ExoPTEN exosome-based therapy in spinal cord injury treatment.
Product Name : ExoPTEN
Product Type : Miscellaneous
Upfront Cash : Undisclosed
March 22, 2024
Lead Product(s) : Exosome
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Preclinical
Sponsor : NurExone Biologic
Deal Size : Undisclosed
Deal Type : Agreement
